Net Income

A new stem cell therapy promises a one-time cure for hemophilia A, and the FDA is clearing the path. Could lifelong, costly infusions become a memory?

With revenues up 18.8% and orders surging 110%, STL is leveraging its advanced fiber tech to become a key player in the booming AI data centre market.

GD Culture Group launches 'Fato', an AI-powered interactive novel, in a bold pivot. Can it disrupt a growing market or will it be lost in the hype?

Student entrepreneurs from 15 countries converge in San Diego to pitch world-changing ideas, from pineapple-fiber hair ties to crypto for Gen Z.

With patient enrollment accelerating for its novel lung fibrosis drug, LTI-03, Rein Therapeutics signals progress in a field desperate for new options.

A modest 0.4% Q1 gain for Canadian pensions masks a dramatic story of geopolitical shocks, a booming energy sector, and a deep tech selloff.

Seattle startup CounterX Therapeutics to present its novel overdose prevention drug at a top investor event, signaling new hope in the fentanyl crisis.

Alibaba's Accio Work deploys AI "business teams" to SMEs, managing e-commerce and even launching physical products from scratch for a new era of business.

A new national ranking moves beyond funding and publications to reveal which U.S. research institutions are truly effective at creating real-world cures.

The largest deal in epigenetic testing sees TruDiagnostic's parent buy Dr. David Sinclair's Tally Health, aiming to make personalized longevity mainstream.

The U.S. Highbush Blueberry Council is betting on startups to find new uses for blueberries in everything from skincare to pet food. Here's what's next.

With a new industry giant on its board and fresh funding, Phagenesis is set to scale its groundbreaking neuromodulation therapy for swallowing disorders.

With huge energy needs, Israel's water company Mekorot turns to nT-Tao's fusion tech in a bold move that could redefine national infrastructure resilience.

As AI and usage-based pricing complicate finance, BillingPlatform launches RevVenue, an expert-led hub to help firms navigate a new era of compliance risk.

The trading signal provider is rolling out new automated tools, touting major Q1 gains. But how do its claims stack up in a competitive, skeptical market?

With staggering 34% revenue growth, United Imaging is leveraging R&D and global expansion to disrupt the Western-dominated medical imaging market.

The Emmy-nominated documentary 'Bribe, Inc.' uncovers the massive Unaoil scandal, highlighting the risky work of journalists and the role of film.

KCIC's 2025 report shows asbestos filings hitting a new peak, driven by a dramatic rise in talc-related lawsuits and massive jury awards.

A new campaign aims to save a major research hub, igniting a debate over its economic benefits, medical breakthroughs, and the future of animal testing.

Anika Therapeutics posts strong Q1 results with a 13% revenue jump, but analyst caution lingers over pipeline risks and long-term sustainability.